Detalhe da pesquisa
1.
Nintedanib in Progressive Fibrosing Interstitial Lung Diseases.
N Engl J Med
; 381(18): 1718-1727, 2019 10 31.
Artigo
Inglês
| MEDLINE | ID: mdl-31566307
2.
Nintedanib in progressive interstitial lung diseases: data from the whole INBUILD trial.
Eur Respir J
; 59(3)2022 03.
Artigo
Inglês
| MEDLINE | ID: mdl-34475231
3.
Effects of nintedanib by inclusion criteria for progression of interstitial lung disease.
Eur Respir J
; 59(2)2022 02.
Artigo
Inglês
| MEDLINE | ID: mdl-34210788
4.
Predictors of mortality in subjects with progressive fibrosing interstitial lung diseases.
Respirology
; 27(4): 294-300, 2022 04.
Artigo
Inglês
| MEDLINE | ID: mdl-35224814
5.
Two first-in-human studies of xentuzumab, a humanised insulin-like growth factor (IGF)-neutralising antibody, in patients with advanced solid tumours.
Br J Cancer
; 122(9): 1324-1332, 2020 04.
Artigo
Inglês
| MEDLINE | ID: mdl-32161368
6.
The natural history of progressive fibrosing interstitial lung diseases.
Eur Respir J
; 55(6)2020 06.
Artigo
Inglês
| MEDLINE | ID: mdl-32217654
7.
Afatinib plus vinorelbine versus trastuzumab plus vinorelbine in patients with HER2-overexpressing metastatic breast cancer who had progressed on one previous trastuzumab treatment (LUX-Breast 1): an open-label, randomised, phase 3 trial.
Lancet Oncol
; 17(3): 357-366, 2016 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-26822398
8.
A phase 1 dose escalation study of BI 831266, an inhibitor of Aurora kinase B, in patients with advanced solid tumors.
Invest New Drugs
; 33(2): 409-22, 2015 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-25529193
9.
A phase I trial investigating the Aurora B kinase inhibitor BI 811283 in combination with cytarabine in patients with acute myeloid leukaemia.
Br J Haematol
; 185(3): 583-587, 2019 05.
Artigo
Inglês
| MEDLINE | ID: mdl-30450591
10.
Nintedanib in patients with progressive fibrosing interstitial lung diseases-subgroup analyses by interstitial lung disease diagnosis in the INBUILD trial: a randomised, double-blind, placebo-controlled, parallel-group trial.
Lancet Respir Med
; 8(5): 453-460, 2020 05.
Artigo
Inglês
| MEDLINE | ID: mdl-32145830
11.
Phase I trial of afatinib and 3-weekly trastuzumab with optimal anti-diarrheal management in patients with HER2-positive metastatic cancer.
Cancer Chemother Pharmacol
; 82(6): 979-986, 2018 12.
Artigo
Inglês
| MEDLINE | ID: mdl-30350178
12.
A phase I study of two dosing schedules of oral BI 847325 in patients with advanced solid tumors.
Cancer Chemother Pharmacol
; 77(1): 99-108, 2016 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-26650227
13.
Pharmacokinetics of afatinib in subjects with mild or moderate hepatic impairment.
Cancer Chemother Pharmacol
; 74(2): 267-75, 2014 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-24906422
14.
Pharmacokinetics of afatinib, a selective irreversible ErbB family blocker, in patients with advanced solid tumours.
Clin Pharmacokinet
; 52(12): 1101-9, 2013 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-23813493